Investigating how ALK4 affects pancreatic cancer biology and receptor trafficking
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology
This study is looking at how a protein called ALK4 affects pancreatic cancer and how its loss might change how the cancer grows and responds to treatments, with the hope of finding better ways to help patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10682545 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of ALK4, a receptor involved in cell signaling, in the context of pancreatic cancer. Researchers aim to explore how the loss of ALK4 expression impacts cancer progression and the effectiveness of treatments. By studying the mechanisms of receptor trafficking and glycosylation, the project seeks to uncover new insights into how pancreatic cancer cells invade and metastasize. Patients may benefit from findings that could lead to improved therapeutic strategies targeting ALK4 and related pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer, particularly those with mutations or loss of ALK4 expression.
Not a fit: Patients with pancreatic cancer who do not have alterations in ALK4 may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that improve survival rates for pancreatic cancer patients.
How similar studies have performed: While the specific approach of targeting ALK4 in pancreatic cancer is novel, similar studies have shown promise in other cancers by targeting receptor signaling pathways.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Blobe, Gerard C — Duke University
- Study coordinator: Blobe, Gerard C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.